{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T14:17:00Z","timestamp":1784557020599,"version":"3.55.0"},"reference-count":13,"publisher":"Bioscientifica","issue":"4","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["edm.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,10,1]]},"abstract":"<jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>A 20-year-old South Asian male presented with polyuria, polydipsia, HbA1c 81 mmol\/mol, BMI 28.8 and family history of both type 1 and type 2 diabetes mellitus. As autoantibody testing was negative and c-peptide level demonstrated significant endogenous insulin secretion, type 1 diabetes was excluded. Given his age and family history, the differential diagnosis included maturity-onset diabetes of the young (MODY), a rare form of diabetes caused by a single-gene variant. A high probability of MODY was calculated and he was subsequently referred for genetic testing. Although a useful tool, the pre-test probability calculator for MODY is only validated in White Europeans. A heterogenous variant of unknown clinical significance of the NEUROD1 gene was detected, leading to gliclazide use with poor response. The patient responded well to metformin. Type 2 diabetes was considered the most likely diagnosis. This case highlights the diagnostic challenges in young patients of Asian ethnicity and the importance of interpreting genetic results of unknown significance within the clinical context. Ethnicity-specific BMI thresholds should be used when classifying patients as overweight or obese.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Learning points<\/jats:title>\n                    <jats:list list-type=\"bullet\">\n                      <jats:list-item>\n                        <jats:p>Variants of unknown significance detected by genetic sequencing should be interpreted within the context of the patient\u2019s other clinical parameters.<\/jats:p>\n                      <\/jats:list-item>\n                      <jats:list-item>\n                        <jats:p>It is important to use ethnicity-specific BMI thresholds for obesity.<\/jats:p>\n                      <\/jats:list-item>\n                      <jats:list-item>\n                        <jats:p>Diagnosis of type 2 diabetes mellitus at younger ages is becoming increasingly common.<\/jats:p>\n                      <\/jats:list-item>\n                      <jats:list-item>\n                        <jats:p>The pre-test probability calculator for MODY is only validated in White Europeans; although a useful guide, results should be interpreted with caution in patients of other ethnicities.<\/jats:p>\n                      <\/jats:list-item>\n                    <\/jats:list>\n                  <\/jats:sec>","DOI":"10.1530\/edm-23-0024","type":"journal-article","created":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T05:30:56Z","timestamp":1697088656000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-2","source":"Crossref","is-referenced-by-count":0,"title":["Diagnostic pitfalls in a young adult with new diabetes"],"prefix":"10.1530","volume":"2023","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9203-3966","authenticated-orcid":true,"given":"Natalie","family":"Below","sequence":"first","affiliation":[{"name":"Diabetes Centre, Gartnavel General Hospital, Glasgow, UK"},{"name":"University of Glasgow, Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Morrison","sequence":"additional","affiliation":[{"name":"Diabetes Centre, Gartnavel General Hospital, Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"McGowan","sequence":"additional","affiliation":[{"name":"West of Scotland Centre for Genomic Medicine, Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory C","family":"Jones","sequence":"additional","affiliation":[{"name":"Diabetes Centre, Gartnavel General Hospital, Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","reference":[{"key":"bib1","series-title":"Diabetes, Metabolic Syndrome and Obesity","first-page":"1047","article-title":"Maturity-onset diabetes of the young (MODY): current perspectives on diagnosis and treatment","volume":"2019","author":"Urakami","year":"2019","unstructured":"Urakami T. Maturity-onset diabetes of the young (MODY): current perspectives on diagnosis and treatment. Diabetes, Metabolic Syndrome and Obesity201920191047\u20131056. (https:\/\/doi.org\/10.2147\/dmso.s179793)"},{"key":"bib2","series-title":"Diabetes Therapy: Research, Treatment and Education of Diabetes and Related Disorders","first-page":"1667","article-title":"Treatment options for MODY patients: a systematic review of literature","volume":"11","author":"Delvecchio","year":"2020","unstructured":"Delvecchio MPastore C & Giordano P. Treatment options for MODY patients: a systematic review of literature. Diabetes Therapy: Research, Treatment and Education of Diabetes and Related Disorders2020111667\u20131685. (https:\/\/doi.org\/10.1007\/s13300-020-00864-4)"},{"key":"bib3","series-title":"Nature Reviews Endocrinology","first-page":"200","article-title":"Clinical implications of a molecular genetic classification of monogenic beta-cell diabetes","volume":"4","author":"Murphy","year":"2008","unstructured":"Murphy REllard S & Hattersley AT. Clinical implications of a molecular genetic classification of monogenic beta-cell diabetes. Nature Reviews Endocrinology20084200\u2013213. (https:\/\/doi.org\/10.1038\/ncpendmet0778)"},{"key":"bib4","series-title":"Journal of Epidemiology and Global Health","first-page":"107","article-title":"Epidemiology of type 2 diabetes \u2013 global burden of disease and forecasted trends","volume":"10","author":"Khan","year":"2020","unstructured":"Khan MABHashim MJKing JKGovender RDMustafa H & Al Kaabi J. Epidemiology of type 2 diabetes \u2013 global burden of disease and forecasted trends. Journal of Epidemiology and Global Health202010107\u2013111. (https:\/\/doi.org\/10.2991\/jegh.k.191028.001)"},{"key":"bib5","series-title":"Lancet. Diabetes and Endocrinology","first-page":"69","article-title":"Type 2 diabetes in adolescents and young adults","volume":"6","author":"Lascar","year":"2018","unstructured":"Lascar NBrown JPattison HBarnett AHBailey CJ & Bellary S. Type 2 diabetes in adolescents and young adults. Lancet. Diabetes and Endocrinology2018669\u201380. (https:\/\/doi.org\/10.1016\/S2213-8587(1730186-9)"},{"key":"bib6","series-title":"Current Diabetes Reports","first-page":"12","article-title":"Genetic dissection and clinical features of MODY6 (NEUROD1-MODY)","volume":"19","author":"Horikawa","year":"2019","unstructured":"Horikawa Y & Enya M. Genetic dissection and clinical features of MODY6 (NEUROD1-MODY). Current Diabetes Reports20191912. (https:\/\/doi.org\/10.1007\/s11892-019-1130-9)"},{"key":"bib7","series-title":"Diabetologia","first-page":"1265","article-title":"The development and validation or a clinical prediction model to determine the probability of MODY in patients with young-onset diabetes","volume":"55","author":"Shields","year":"2012","unstructured":"Shields BMMcDonald TJEllard SCampbell MJHyde C & Hattersley AT. The development and validation or a clinical prediction model to determine the probability of MODY in patients with young-onset diabetes. Diabetologia2012551265\u20131272. (https:\/\/doi.org\/10.1007\/s00125-011-2418-8)"},{"key":"bib8","series-title":"Endocrinology, Diabetes and Metabolism","first-page":"e00332","article-title":"MODY probability calculator utility in individuals' selection for genetic testing: its accuracy and performance","volume":"5","author":"da Silva Santos","year":"2022","unstructured":"da Silva Santos TFonseca LSantos Monteiro SBorges Duarte DMartins Lopes ACouto de Carvalho AOliveira MJBorges TLaranjeira FCouce ML, MODY probability calculator utility in individuals' selection for genetic testing: its accuracy and performance. Endocrinology, Diabetes and Metabolism20225e00332. (https:\/\/doi.org\/10.1002\/edm2.332)"},{"key":"bib9","series-title":"Nature","first-page":"434","article-title":"The mutational constraint spectrum quantified from variation in 141,456 humans","volume":"581","author":"Karczewski","year":"2020","unstructured":"Karczewski KJFrancioli LCTiao GCummings BBAlf\u00f6ldi JWang QCollins RLLaricchia KMGanna ABirnbaum DP, The mutational constraint spectrum quantified from variation in 141,456 humans. Nature2020581434\u2013443. (https:\/\/doi.org\/10.1038\/s41586-020-2308-7)"},{"key":"bib10","year":"2020","unstructured":"National Institutes of Health (NIH). ClinVar[VCV000718631.4]. Bethesda, MD, USA: National Library of Medicine, National Institutes of Health (NIH), 2020. (available at: https:\/\/www.ncbi.nlm.nih.gov\/clinvar\/variation\/718631\/)"},{"key":"bib11","year":"2020","unstructured":"Ellard SBaple ELCallaway ABerry IForrester NTurnbull COwens MEccles DMAbbs SScott R ACGS best practice guidelines for variant classification in rare disease 2020. London, UK: Association for Clinical Genomic Science (ACGS), 2020. (available at: https:\/\/www.acgs.uk.com\/media\/11631\/uk-practice-guidelines-for-variant-classification-v4-01-2020.pdf)"},{"key":"bib12","series-title":"Lancet. Diabetes and Endocrinology","first-page":"419","article-title":"Ethnicity-specific BMI cutoffs for obesity based on type 2 diabetes risk in England: a population-based cohort study","volume":"9","author":"Caleyachetty","year":"2021","unstructured":"Caleyachetty RBarber TMMohammed NICappuccio FPHardy RMathur RBanerjee A & Gill P. Ethnicity-specific BMI cutoffs for obesity based on type 2 diabetes risk in England: a population-based cohort study. Lancet. Diabetes and Endocrinology20219419\u2013426. (https:\/\/doi.org\/10.1016\/S2213-8587(2100088-7)"},{"key":"bib13","year":"2023","unstructured":"National Institute for Health and Care Excellence (NICE). Obesity: identification, assessment and management 2022. London, UK: Guidance, NICE, 2023. (available at: https:\/\/www.nice.org.uk\/guidance\/cg189\/chapter\/Recommendations)"}],"container-title":["Endocrinology, Diabetes &amp; Metabolism Case Reports"],"original-title":[],"link":[{"URL":"https:\/\/edm.bioscientifica.com\/view\/journals\/edm\/2023\/4\/EDM23-0024.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/edm.bioscientifica.com\/downloadpdf\/journals\/edm\/2023\/4\/EDM23-0024.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/edm.bioscientifica.com\/downloadpdf\/journals\/edm\/2023\/4\/EDM23-0024.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T13:48:12Z","timestamp":1784555292000},"score":1,"resource":{"primary":{"URL":"http:\/\/journals.bioscientifica.com\/edm\/article\/3590"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,1]]},"references-count":13,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.1530\/edm-23-0024","relation":{},"ISSN":["2052-0573"],"issn-type":[{"value":"2052-0573","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,1]]}}}